Core Viewpoint - The "Implementation Plan for the Digital and Intelligent Transformation of the Pharmaceutical Industry (2025-2030)" aims to enhance the efficiency, quality, and innovation capabilities of the pharmaceutical industry through digital transformation and the application of technologies like artificial intelligence [1][2]. Group 1: Transformation Goals - By 2027, the plan targets breakthroughs in key technologies, the establishment of over 30 technical standards, and the development of more than 100 high-performance products in smart pharmaceutical equipment and software [2]. - The plan aims for full coverage of digital transformation among large-scale pharmaceutical enterprises by 2030 [2]. Group 2: Key Actions - The plan outlines four main action areas: empowering with digital technology, promoting digital transformation, building a supportive service system, and enhancing regulatory capabilities [3][4][5][6]. - Specific tasks include developing exemplary application scenarios, fostering leading enterprises, and establishing innovation platforms [2][6]. Group 3: Industry Impact - The digital transformation is expected to accelerate the entire pharmaceutical supply chain, improving collaboration and operational efficiency from raw material suppliers to healthcare institutions [7]. - AI-driven platforms are anticipated to significantly reduce drug development cycles and costs, facilitating faster market entry for new drugs [8][10]. Group 4: Traditional Medicine Modernization - The digital transformation will also support the modernization and internationalization of traditional Chinese medicine, enhancing its quality and consistency through automated production processes [8][10]. - AI technologies are being utilized to optimize traditional medicine formulations and predict new indications, thereby streamlining the research and development process [8][10].

Core Viewpoint - The "Implementation Plan for the Digital and Intelligent Transformation of the Pharmaceutical Industry (2025-2030)" aims for comprehensive digital transformation of large-scale pharmaceutical enterprises by 2030, enhancing competitiveness and ensuring drug quality and supply security [1][2] Group 1: Development Goals - By 2027, significant progress in digital transformation is expected, including breakthroughs in key technologies and the development of over 100 high-performance products in smart pharmaceutical equipment and software [1] - More than 100 intelligent pharmaceutical factories and over 10 innovation platforms for pharmaceutical models and technology applications are to be established by 2027 [1] - By 2030, large-scale pharmaceutical enterprises are expected to achieve full coverage of digital transformation, with enhanced innovation capabilities and a more complete data system across the pharmaceutical industry [1] Group 2: Specific Actions - The plan outlines 14 specific tasks focusing on four main areas: empowering actions through digital technology, promoting digital transformation, building a digital service system, and enhancing digital supervision [2] - It encourages collaboration among pharmaceutical companies, medical institutions, and research institutes to build a pharmaceutical big data platform for high-quality data collection across various fields [2] - The establishment of high-performance cloud computing platforms, blockchain, data centers, and other information infrastructure is encouraged to support the digital transformation of pharmaceutical enterprises [2] Group 3: Policy Support - The Ministry of Industry and Information Technology will strengthen policy coordination and increase support for the digital transformation of the pharmaceutical industry through national science and technology projects [2] - Local governments are encouraged to enhance resource support and promote cross-regional cooperation among pharmaceutical enterprises and their supply chains [2] - The plan also aims to align domestic and international regulations, standards, and technical exchanges in the field of pharmaceutical digitalization [2]

一、ETF行业快讯1.三大指数涨跌互现，多只创新药主题ETF涨超1% 今日，三大指数涨跌互现，上证综指上涨0.03%，深证成指下跌0.58%， 创业板指下跌0.68%。多只创新 药主题ETF上涨，其中，创新药ETF富国（159748.SZ）上涨1.48%，创新药企ETF（560900.SH）上涨 1.16%。计算机板块多只ETF下跌，金融科技ETF（159851.SZ）下跌3.07%，金融科技ETF华夏 （516100.SH）下跌3.05%，金融科技ETF（516860.SH）下跌3.00%。 消息面上，工业和信息化部等七部门印发《医药工业数智化转型实施方案（2025—2030年）》的通知， 其中提出，深化人工智能赋能应用。支持相关单位建立医药大模型创新平台，协同开展医药大模型技术 产品研发、监管科学研究等，强化标准规范、科技伦理、应用安全和风险管理等规则建设。开展"人工 智能赋能医药全产业链"应用试点，鼓励龙头医药企业与医疗机构、科研院所、上下游企业、大用户等 组成联合体，面向医药全产业链形成一批效果显著的标志性应用场景。鼓励各地建设医药人工智能领域 概念验证、中试验证、共性技术、知识产权运营、开源社区等公 ...

工信部等七部门：落实数据基础制度，推进医药工业公共数据规范化开发利用 金十数据4月24日讯，工信部等七部门关于印发《医药工业数智化转型实施方案（2025—2030年）》， 其中提到，鼓励医药企业、医疗机构、科研院所等合作建设医药工业大数据平台，形成研发、生产、临 床、大健康等领域高质量数据集，推进数据分类分级管理和数据要素市场试点。落实数据基础制度，推 进医药工业公共数据规范化开发利用，完善医药工业数据产权归属认定、市场交易、权益分配、利益保 护等具体规则，培育专业化医药数据服务企业，支持数据交易机构开展医药工业数据流通共享探索。推 动落实数据管理能力成熟度、个人信息保护等评估，规范医药工业数据跨境传输管理。 ...

Group 1 - The core viewpoint of the article emphasizes the strengthening of research and application of intelligent products in the pharmaceutical industry as outlined in the "Implementation Plan for the Digital Transformation of the Pharmaceutical Industry (2025-2030)" issued by the Ministry of Industry and Information Technology and six other departments [1] - The plan includes organizing "challenge" initiatives for pharmaceutical digital solutions and technology products, targeting the production characteristics of various sub-sectors such as chemical drugs, traditional Chinese medicine, biological products, and medical devices [1] - The initiative aims to develop a series of intelligent pharmaceutical equipment and testing devices, as well as to create "small, fast, light, and precise" pharmaceutical industrial software or systems that comply with the Good Practice (GXP) quality management system [1]

金十数据4月24日讯，工信部等七部门关于印发《医药工业数智化转型实施方案（2025—2030年）》， 其中提到，统筹国家科技项目渠道加大对医药工业数智化转型的支持，落实首台（套）重大技术装备、 大规模设备更新、技术改造、软件产品等政策，优化审评前置等监管政策，支持医药工业数智技术、产 品的研发与推广应用。鼓励地方加强要素保障，统筹项目、融资、用地、用能等支持政策，促进医药企 业数智化建设重点项目尽快落地见效。发挥国家产融合作平台作用，引导金融机构为医药工业数智化转 型项目提供中长期贷款、供应链金融、融资租赁、上市辅导等金融服务。 工信部等七部门：引导金融机构为医药工业数智化转型项目提供中长期贷款、供应链金融、融资租赁、 上市辅导等金融服务 ...

工业和信息化部等七部门发布关于印发《医药工业数智化转型实施方案（2025—2030年）》的通知。其 中提出，到2027年，医药工业数智化转型取得重要进展，以数智技术驱动的医药全产业链竞争力和全生 命周期质量管理水平显著提升。 ...